Resolutions of the National Council for the Setting and Review of Prices of Medications for Human Use and Consumption – Ministry of Public Health

by time news

2023-08-01 23:12:16
No. ResolutionApproval date ResolutionsNro. Council SessionAffairLink10-2015August 19, 2015637Price List Ceiling of Strategic Medicines and RegisteredDescargar 11-2016 April 08, 2016 646Deadline for depletion of stocks medications listed in Resolution No. 10 of October 8, 2015 Descargar 04-651 June 24, 2016 651Errata to the Ceiling Price List published by Resolution No. 10 of October 08, 2015 Descargar13-2016October 14, 2016660Term for depletion of stocks to the sector pharmacistDescargar STLM 11-658 September 23, 2016 658Setting the ceiling price for the drug market segments: rituximab 100 mg, solution for injection and rituximab 500 mg, solution for injection Descargar STLM 12-659 September 29, 2016 659Setting the ceiling price for the market segment of the drug paracetamol 500 mg, softgels, oral solid STLM 23-661 October 14, 2016 661Elimination of items 145 and 147 of the Ceiling Price List published by Resolution No. 10-2015 STLM 24-661 October 14, 2016 661Ratification of the ceiling price of the market segment cotrimoxazole (200 mg +40 mg) 5 ml, oral suspension, oral liquid; published by Resolution No. 10-2015. Elimination of items 574 and 575 from the Ceiling Price List published by Resolution No. 10-2015 STLM 34-664 December 1, 2016 664Modification to the expression of the ceiling price of the market segment: amoxicillin + clavulanic acid, (400 mg + 57 mg)/ 5ml, powder for suspension, oral solid. Descargar STLM 41-665 December 22, 2016 665Modification to the expression of the ceiling price of the market segment: erythromycin 400mg/5ml, powder for suspension, oral solid STLM 42-665 December 22, 2016 665Modification to the expression of the ceiling price of the Market Segment: Estriol, 1mg/g, Vaginal Cream, Semisolid STLM 46-666 January 6, 2017 666Modification to the expression of the ceiling price of the market segment: propofol 10 mg/ml, emulsion injectable, parenteral liquid STLM 47-668 January 26, 2017 668Modification to the expression of the ceiling price of the market segment: rivastigmine 1.8 mg/cm 2 , transdermal patch, skin solid STLM 48-668 January 26, 2017 668Modification to the expression of the ceiling price of the market segment: potassium chloride 2 meq/ml, solution for infusion, parenteral liquid
#Resolutions #National #Council #Setting #Review #Prices #Medications #Human #Consumption #Ministry #Public #Health

You may also like

Leave a Comment